BR9709068A - Processo de tratamento. - Google Patents
Processo de tratamento.Info
- Publication number
- BR9709068A BR9709068A BR9709068-9A BR9709068A BR9709068A BR 9709068 A BR9709068 A BR 9709068A BR 9709068 A BR9709068 A BR 9709068A BR 9709068 A BR9709068 A BR 9709068A
- Authority
- BR
- Brazil
- Prior art keywords
- amount
- mammal
- interferon
- treatment process
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Chemical Treatment Of Metals (AREA)
- Medicines Containing Plant Substances (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção:<B>"PROCESSO DE TRATAMENTO"<D>. Composição de interferon para contato oromucosal para estimular mecanismos de defesa de hospedeiro ou uma imunorresposta, em um mamífero, com uma quantidade estimulante do interferon que exceda quantidades de interferon administradas parentalmente, processos de tratamento com tais composições e usos de interferon na preparação de tais composições oromucosais.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN9765A AUPN976596A0 (en) | 1996-05-09 | 1996-05-09 | Stimulation of host defence mechanisms |
AUPO3959A AUPO395996A0 (en) | 1996-12-03 | 1996-12-03 | Stimulation of host defence mechanisms |
AUPO4387A AUPO438796A0 (en) | 1996-12-24 | 1996-12-24 | Method of treatment |
PCT/IB1997/000490 WO1997041884A1 (en) | 1996-05-09 | 1997-05-05 | Method of treatment |
US08/853,292 US6361769B1 (en) | 1996-05-09 | 1997-05-09 | Stimulation of host defense mechanisms against viral challenges |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9709068A true BR9709068A (pt) | 2000-01-11 |
Family
ID=27424412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9709068-9A BR9709068A (pt) | 1996-05-09 | 1997-05-05 | Processo de tratamento. |
Country Status (15)
Country | Link |
---|---|
US (1) | US6361769B1 (pt) |
EP (1) | EP0906119B1 (pt) |
JP (1) | JP3806445B2 (pt) |
CN (1) | CN1151841C (pt) |
AT (1) | ATE316792T1 (pt) |
AU (1) | AU724689B2 (pt) |
BR (1) | BR9709068A (pt) |
CA (1) | CA2253971A1 (pt) |
DE (1) | DE69735202T2 (pt) |
ES (1) | ES2260791T3 (pt) |
ID (1) | ID17768A (pt) |
IL (2) | IL126971A0 (pt) |
NZ (1) | NZ332689A (pt) |
TW (1) | TW482676B (pt) |
WO (1) | WO1997041884A1 (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN976596A0 (en) * | 1996-05-09 | 1996-05-30 | Pharma Pacific Pty Ltd | Stimulation of host defence mechanisms |
US20020058674A1 (en) | 1999-01-08 | 2002-05-16 | Hedenstrom John C. | Systems and methods for treating a mucosal surface |
US6486168B1 (en) | 1999-01-08 | 2002-11-26 | 3M Innovative Properties Company | Formulations and methods for treatment of mucosal associated conditions with an immune response modifier |
SK287112B6 (sk) | 1999-01-08 | 2009-12-07 | 3M Innovative Properties Company | Použitie zlúčeniny modifikujúcej imunitnú odpoveď pri liečení cervikálnej dysplázie |
EP1602378A1 (en) * | 1999-12-09 | 2005-12-07 | Chiron Corporation | Method for administering a cytokine to the central nervous system and the lymphatic system |
IL150109A0 (en) | 1999-12-09 | 2002-12-01 | Chiron Corp | Method for administering a cytokine to the central nervous system and the lymphatic system |
US6770666B2 (en) | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
CN1623984A (zh) | 1999-12-27 | 2005-06-08 | 日本烟草产业株式会社 | 稠环化合物及其药物用途 |
US6415797B1 (en) * | 2000-07-07 | 2002-07-09 | First Circle Medical, Inc. | Treatment of human herpesviruses using hyperthermia |
AR035543A1 (es) * | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
DE60332358D1 (de) * | 2002-09-09 | 2010-06-10 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
US20050031587A1 (en) * | 2002-10-04 | 2005-02-10 | Yamanouchi Pharmaceutical Co., Ltd. | Immune response induction method |
WO2004033499A1 (ja) * | 2002-10-11 | 2004-04-22 | Chugai Seiyaku Kabushiki Kaisha | 細胞死誘導剤 |
US20050267144A1 (en) * | 2003-01-06 | 2005-12-01 | Eugene Mandrea | Methods of stimulating immune response in virally infected individuals |
US7893083B2 (en) * | 2003-01-06 | 2011-02-22 | Eugene Mandrea | Method of treating genital herpes |
US20040136917A1 (en) * | 2003-01-06 | 2004-07-15 | Eugene Mandrea | Methods of stimulating immune response in virally infected individuals |
US20060183767A1 (en) * | 2003-01-06 | 2006-08-17 | Eugene Mandrea | Methods of stimulating immune response in certain individuals |
TW200530269A (en) * | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Anti-Mpl antibodies |
TW200530266A (en) * | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Method of reinforcing antibody activity |
EP1712565A4 (en) * | 2003-12-12 | 2009-03-11 | Chugai Pharmaceutical Co Ltd | AGENTS INDUCING CELL DEATH |
WO2005100560A1 (ja) * | 2004-04-09 | 2005-10-27 | Chugai Seiyaku Kabushiki Kaisha | 細胞死誘導剤 |
EA200700017A1 (ru) * | 2004-06-12 | 2009-06-30 | Ле Сантр Насьональ Де Ля Решерш Сьентифик ( Снрс ) | Способ усиления иммунного ответа на вакцину |
US9493569B2 (en) * | 2005-03-31 | 2016-11-15 | Chugai Seiyaku Kabushiki Kaisha | Structural isomers of sc(Fv)2 |
EP1927367A4 (en) * | 2005-05-18 | 2009-08-12 | Univ Tokushima | NOVEL PHARMACEUTICAL AGENT BASED ON AN ANTI-HLA ANTIBODY |
CA2610987C (en) * | 2005-06-10 | 2013-09-10 | Chugai Seiyaku Kabushiki Kaisha | Stabilizer for protein preparation comprising meglumine and use thereof |
CN101262885B (zh) | 2005-06-10 | 2015-04-01 | 中外制药株式会社 | 含有sc(Fv)2的药物组合物 |
JPWO2008007755A1 (ja) * | 2006-07-13 | 2009-12-10 | 中外製薬株式会社 | 細胞死誘導剤 |
CL2008000719A1 (es) * | 2007-03-12 | 2008-09-05 | Univ Tokushima Chugai Seiyaku | Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a |
US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
KR20110002836A (ko) * | 2008-02-15 | 2011-01-10 | 헤미스펙스 바이오파마 인코포레이티드 | 천연형 인터페론 알파종으로의 점막 노출에 의한 숙주 방어 기전의 유전적 조절 |
CA2764759A1 (en) | 2009-06-09 | 2010-12-16 | Defyrus, Inc. | Administration of interferon for prophylaxis against or treatment of pathogenic infection |
CN102309758B (zh) * | 2010-07-02 | 2013-02-20 | 北京凯因科技股份有限公司 | 一种治疗肠道病毒感染引起的疾病的药物组合物 |
US20130129678A1 (en) | 2011-11-17 | 2013-05-23 | Zahari Raykov | Co-administration of a parvovirus and a cytokine for therapy of pancreatic cancer |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0058192A1 (en) | 1980-08-22 | 1982-08-25 | University of Illinois Foundation | Delivery of biologically active components of heterologous species interferon isolates |
US5286748A (en) * | 1981-01-05 | 1994-02-15 | Eby Iii George A | General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity |
US4605555A (en) * | 1984-09-20 | 1986-08-12 | Sun Star Kabushiki Kaisha | Composition and method for treating keratosic disorder of skin and mucosa |
US4946674A (en) | 1984-10-05 | 1990-08-07 | Bioferon Biochemische Substanzen Gmbh & Co. | Process for treatment of rheumatic diseases |
IL76591A0 (en) * | 1984-10-05 | 1986-02-28 | Bioferon Biochem Substanz | Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof |
US4820514A (en) | 1985-12-30 | 1989-04-11 | Texas A&M University System | Low dosage of interferon to enhance vaccine efficiency |
CA1320905C (en) * | 1986-11-06 | 1993-08-03 | Joseph M. Cummins | Treatment of immuno-resistant disease |
ZA878295B (en) | 1986-11-06 | 1988-05-03 | Amarillo Cell Culture Co. Inc. | Treatment of immuno-resistant disease |
US5017371A (en) | 1988-01-06 | 1991-05-21 | Amarillo Cell Culture Company, Incorporated | Method for reducing side effects of cancer therapy |
JP2704546B2 (ja) * | 1989-04-04 | 1998-01-26 | 光利 太良 | Atll治療用吸入剤 |
US5372808A (en) * | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
US5215741A (en) | 1990-10-30 | 1993-06-01 | Amarillo Cell Culture Company, Incorporated | Method for prevention of parasite infections |
CA2098393A1 (en) * | 1990-12-14 | 1992-06-15 | Robert J. Spiegel | Oral administration of alpha interferon to treat lung malignancies |
WO1992017209A1 (en) | 1991-04-08 | 1992-10-15 | Sumitomo Pharmaceuticals Company, Limited | Porous solid preparation containing physiologically active protein substance |
EP0566135A1 (en) | 1992-04-17 | 1993-10-20 | Takeda Chemical Industries, Ltd. | Transmucosal composition comprising a peptide and a cytidine derivative |
US5780021A (en) * | 1993-03-05 | 1998-07-14 | Georgetown University | Method for treating type 1 diabetes using α-interferon and/or β-i |
JPH06298665A (ja) * | 1993-04-14 | 1994-10-25 | Toray Ind Inc | 抗ウイルス剤 |
IL113280A (en) * | 1994-04-12 | 2004-12-15 | Res Dev Foundation | A preparation for the treatment of self-immunization diseases with the help of interferon of one type |
-
1997
- 1997-05-05 JP JP53969697A patent/JP3806445B2/ja not_active Expired - Fee Related
- 1997-05-05 DE DE69735202T patent/DE69735202T2/de not_active Expired - Fee Related
- 1997-05-05 CA CA002253971A patent/CA2253971A1/en not_active Abandoned
- 1997-05-05 NZ NZ332689A patent/NZ332689A/xx unknown
- 1997-05-05 WO PCT/IB1997/000490 patent/WO1997041884A1/en active IP Right Grant
- 1997-05-05 BR BR9709068-9A patent/BR9709068A/pt not_active IP Right Cessation
- 1997-05-05 AU AU23993/97A patent/AU724689B2/en not_active Ceased
- 1997-05-05 EP EP97919564A patent/EP0906119B1/en not_active Expired - Lifetime
- 1997-05-05 ES ES97919564T patent/ES2260791T3/es not_active Expired - Lifetime
- 1997-05-05 AT AT97919564T patent/ATE316792T1/de not_active IP Right Cessation
- 1997-05-05 CN CNB971945012A patent/CN1151841C/zh not_active Expired - Fee Related
- 1997-05-05 IL IL12697197A patent/IL126971A0/xx active IP Right Grant
- 1997-05-07 TW TW086106144A patent/TW482676B/zh active
- 1997-05-09 US US08/853,292 patent/US6361769B1/en not_active Expired - Fee Related
- 1997-05-09 ID IDP971535A patent/ID17768A/id unknown
-
1998
- 1998-11-08 IL IL126971A patent/IL126971A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL126971A (en) | 2007-12-03 |
JP3806445B2 (ja) | 2006-08-09 |
ID17768A (id) | 1998-01-29 |
CN1218408A (zh) | 1999-06-02 |
TW482676B (en) | 2002-04-11 |
WO1997041884A1 (en) | 1997-11-13 |
AU724689B2 (en) | 2000-09-28 |
CN1151841C (zh) | 2004-06-02 |
EP0906119A1 (en) | 1999-04-07 |
CA2253971A1 (en) | 1997-11-13 |
ATE316792T1 (de) | 2006-02-15 |
ES2260791T3 (es) | 2006-11-01 |
EP0906119B1 (en) | 2006-02-01 |
DE69735202T2 (de) | 2006-11-02 |
DE69735202D1 (de) | 2006-04-13 |
US6361769B1 (en) | 2002-03-26 |
NZ332689A (en) | 2000-07-28 |
IL126971A0 (en) | 1999-09-22 |
EP0906119A4 (en) | 1999-10-20 |
JP2000505478A (ja) | 2000-05-09 |
AU2399397A (en) | 1997-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9709068A (pt) | Processo de tratamento. | |
PT880350E (pt) | Tratamento de esclerose multipla | |
PT94869A (pt) | Processo de preparacao de uma composicao terapeutica a base de moleculas de anticorpos anti-cd14 | |
NO991342D0 (no) | Anvendelse av fumarsyrederivater ved behandling av autoimmune sykdommer | |
ES2136599T3 (es) | Tratamiento de las heridas utilizando peptidos biologicamente activos. | |
DE69835823D1 (de) | Verfahren zur behandlung von patienten die unter multipler sklerose leiden mit konsensus-interferon | |
RU95106651A (ru) | Аналоги дзе-тур динорфина и способ лечения толерантных состояний у пациента | |
BR9809678A (pt) | Derivados de triptolìdeo úteis no tratamento de doenças autoimunes | |
DK0752884T3 (da) | Fremgangsmåde til behandling af auto-immune sygdomme ved anvendelse af type 1 interferoner | |
PT1237562E (pt) | Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas | |
SG125079A1 (en) | Oxazolidinones to treat eye infections | |
MY104521A (en) | Treatment of depression. | |
BR9709223A (pt) | Estimulação dos mecanismos de defesa do hospedeiro contra tumores. | |
AU3308099A (en) | Method for the treatment of pain, including chronic and female specific pain | |
DE69725897D1 (de) | Behandlung von störungen mittels interleukin-9 | |
HK1015692A1 (en) | Ctla-8 in combination with g-csf or with g-csf and il-6, and use of ctla-8, for treating infections | |
AU4530796A (en) | Treating disorders characterised by excessive cell proliferation with sclareolide | |
SU1097329A1 (ru) | Способ лечени беременных с иммунным конфликтом | |
UA15554A (uk) | Спосіб прогhозуваhhя ефективhості рефлексотерапії за лазориком | |
ECSP972109A (es) | Estimulacion de los mecanismos de defensa del huesped contra tumores | |
ECSP972107A (es) | Estimulacion de los mecanismos de defensa del huesped contra estimulaciones virales | |
RU94002713A (ru) | Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда) | |
MX9700626A (es) | USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS. | |
RU95111135A (ru) | Способ лечения нисходящих атрофий зрительного нерва методом прямого электрофореза | |
MX9801038A (es) | Tratamiento de condiciones inflamatorias oculares con interleucina-10. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A , 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1855 DE 25/07/2006. |